Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zealand Pharma A/S (ZLDPF)

Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,695,513
  • Shares Outstanding, K 51,513
  • Annual Sales, $ 49,750 K
  • Annual Income, $ -102,130 K
  • 60-Month Beta 0.67
  • Price/Sales 98.68
  • Price/Cash Flow N/A
  • Price/Book 18.01
Trade ZLDPF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.82
  • Most Recent Earnings $-0.66 on 02/27/24
  • Latest Earnings Date 05/16/24 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +185,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.8600 +8.27%
on 04/22/24
96.3700 -9.15%
on 05/07/24
+0.8000 (+0.92%)
since 04/17/24
3-Month
67.5780 +29.55%
on 02/21/24
111.4400 -21.44%
on 03/07/24
+17.0060 (+24.11%)
since 02/15/24
52-Week
33.4200 +161.97%
on 07/25/23
111.4400 -21.44%
on 03/07/24
+49.8600 (+132.29%)
since 05/16/23

Most Recent Stories

More News
Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss Stock.

The risk is higher, but so is the upside when it comes to Zealand Pharma.

ZLDPF : 87.5500 (-3.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended...

See More

Key Turning Points

3rd Resistance Point 93.2547
2nd Resistance Point 92.2173
1st Resistance Point 91.6847
Last Price 87.5500
1st Support Level 90.1147
2nd Support Level 89.0773
3rd Support Level 88.5447

See More

52-Week High 111.4400
Last Price 87.5500
Fibonacci 61.8% 81.6364
Fibonacci 50% 72.4300
Fibonacci 38.2% 63.2236
52-Week Low 33.4200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar